Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34
Rosello S, Papaccio F, Roda D, Tarazona N, Cervantes A (2018) The role of chemotherapy in localized and locally advanced rectal cancer: a systematic revision. Cancer Treat Rev 63:156–171
Mitra SA, Mitra AP, Triche TJ (2012) A central role for long non-coding RNA in cancer. Front Genet 3:17
Fan Q, Liu B (2018) Comprehensive analysis of a long noncoding RNA-associated competing endogenous RNA network in colorectal cancer. Onco Targets Ther 11:2453–2466
Wei L, Wang X, Lv L, Zheng Y, Zhang N, Yang M (2019) The emerging role of noncoding RNAs in colorectal cancer chemoresistance. Cell Oncol (Dordr) 42:757–768
Xu T, Wu K, Zhang L, et al. (2019) Long non-coding RNA LINC00858 exerts a tumor-promoting role in colon cancer via HNF4alpha and WNK2 regulation. Cell Oncol (Dordr)
Bhan A, Mandal SS (2014) Long noncoding RNAs: emerging stars in gene regulation, epigenetics and human disease. ChemMedChem. 9:1932–1956
Xu Y, Zhang X, Hu X, Zhou W, Zhang P, Zhang J, Yang S, Liu Y (2018) The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9. Mol Med 24:52
Yang F, Liu YH, Dong SY, Ma RM, Bhandari A, Zhang XH, Wang OC (2016) A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer. Biochem Biophys Res Commun 470:479–483
Yang Y, Xun N, Wu JG (2019) Long non-coding RNA FGF14-AS2 represses proliferation, migration, invasion, and induces apoptosis in breast cancer by sponging miR-205-5p. Eur Rev Med Pharmacol Sci 23:6971–6982
Burotto M, Chiou VL, Lee JM, Kohn EC (2014) The MAPK pathway across different malignancies: a new perspective. Cancer. 120:3446–3456
Sun QY, Ding LW, Johnson K, Zhou S, Tyner JW, Yang H, Doan NB, Said JW, Xiao JF, Loh XY, Ran XB, Venkatachalam N, Lao Z, Chen Y, Xu L, Fan LF, Chien W, Lin DC, Koeffler HP (2019) SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells. Oncogene. 38:6196–6210
Pan H, Wang Y, Na K, Wang Y, Wang L, Li Z, Guo C, Guo D, Wang X (2019) Autophagic flux disruption contributes to Ganoderma lucidum polysaccharide-induced apoptosis in human colorectal cancer cells via MAPK/ERK activation. Cell Death Dis 10:456
Zhang X, Ma L, Qi J, Shan H, Yu W, Gu Y (2015)MAPK/ERK signaling pathway-inducedhyper-O-GlcNAcylation enhances cancer malignancy. Mol Cell Biochem 410:101–110
Finlin BS, Gau CL, Murphy GA, Shao H, Kimel T, Seitz RS, Chiu YF, Botstein D, Brown PO, der CJ, Tamanoi F, Andres DA, Perou CM (2001) RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. J Biol Chem 276:42259–42267
Habashy HO, Powe DG, Glaab E, Ball G, Spiteri I, Krasnogor N, Garibaldi JM, Rakha EA, Green AR, Caldas C, Ellis IO (2011) RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype. Breast Cancer Res Treat 128:315–326
Wang AG, Fang W, Han YH, Cho SM, Choi JY, Lee KH, Kim WH, Kim JM, Park MG, Yu DY, Kim NS, Lee DS (2006) Expression of the RERG gene is gender-dependent in hepatocellular carcinoma and regulated by histone deacetyltransferases. J Korean Med Sci 21:891–896
Xiong Y, Huang H, Chen S, Dai H, Zhang L (2019) ERK5regulated RERG expression promotes cancer progression in prostatic carcinoma. Oncol Rep 41:1160–1168
Yang R, Chen B, Pfutze K, Buch S, Steinke V, Holinski-Feder E, Stocker S, von Schonfels W, Becker T, Schackert HK, Royer-Pokora B, Kloor M, Schmiegel WH, Buttner R, Engel C, Lascorz Puertolas J, Forsti A, Kunkel N, Bugert P, Schreiber S, Krawczak M, Schafmayer C, Propping P, Hampe J, Hemminki K, Burwinkel B (2014)Genome-wide analysis associates familial colorectal cancer with increases in copy number variations and a rare structural variation at 12p12.3. Carcinogenesis. 35:315–323
Chen Y, Yu X, Xu Y, Shen H (2017) Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis. Cancer Med 6:2321–2330
Berg M, Soreide K (2012) EGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways in colorectal cancer: implications for targeted therapy. Discov Med 14:207–214
Berg M, Danielsen SA, Ahlquist T, Merok MA, Ågesen TH, Vatn MH, Mala T, Sjo OH, Bakka A, Moberg I, Fetveit T, Mathisen Ø, Husby A, Sandvik O, Nesbakken A, Thiis-Evensen E, Lothe RA (2010) DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset. PLoS One 5:e13978
Wang Q, Yang L, Hu X, Jiang Y, Hu Y, Liu Z, Liu J, Wen T, Ma Y, An G, Feng G (2017) Upregulated NNT-AS1, a long noncoding RNA, contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo. Oncotarget. 8:3441–3453
Sang B, Zhang YY, Guo ST, Kong LF, Cheng Q, Liu GZ, Thorne RF, Zhang XD, Jin L, Wu M (2018) Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence. Proc Natl Acad Sci U S A 115:E11661–E11E70
Zhao W, Ma N, Wang S, Mo Y, Zhang Z, Huang G, Midorikawa K, Hiraku Y, Oikawa S, Murata M, Takeuchi K (2017) RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-kappaB signaling pathway in nasopharyngeal carcinoma. J Exp Clin Cancer Res 36:88
Ho JY, Hsu RJ, Liu JM, Chen SC, Liao GS, Gao HW, Yu CP (2017)MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis. Oncotarget. 8:22443–22459
Zhang Y, Ren S, Yuan F et al (2018)miR-135 promotes proliferation and stemness of oesophageal squamous cell carcinoma by targeting RERG. Artif Cells Nanomed Biotechnol 46:1210–1219
Gopalan V, Pillai S, Ebrahimi F, Salajegheh A, Lam TC, le TK, Langsford N, Ho YH, Smith RA, Lam AKY (2014) Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance. Mol Carcinog 53(Suppl 1):E36–E44
Comments (0)